Literature DB >> 4371315

Immunotherapy of guinea pig cancer with BCG.

B Zbar, H J Rapp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4371315     DOI： 10.1002/1097-0142(197410)34:8+<1532::aid-cncr2820340827>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  16 in total

Review 1.  Landmarks in non-muscle-invasive bladder cancer.

Authors:  Laura S Mertens; Yann Neuzillet; Simon Horenblas; Bas W G van Rhijn
Journal:  Nat Rev Urol       Date:  2014-07-01       Impact factor: 14.432

2.  A Festschrift in Honor of Edward M. Messing, MD, FACS.

Authors:  Jean V Joseph; Ralph Brasacchio; Chunkit Fung; Jay Reeder; Kevin Bylund; Deepak Sahasrabudhe; Shu Yuan Yeh; Ahmed Ghazi; Patrick Fultz; Deborah Rubens; Guan Wu; Eric Singer; Edward Schwarz; Supriya Mohile; James Mohler; Dan Theodorescu; Yi Fen Lee; Paul Okunieff; David McConkey; Hani Rashid; Chawnshang Chang; Yves Fradet; Khurshid Guru; Janet Kukreja; Gerald Sufrin; Yair Lotan; Howard Bailey; Katia Noyes; Seymour Schwartz; Kathy Rideout; Gennady Bratslavsky; Steven C Campbell; Ithaar Derweesh; Per-Anders Abrahamsson; Mark Soloway; Leonard Gomella; Dragan Golijanin; Robert Svatek; Thomas Frye; Seth Lerner; Ganesh Palapattu; George Wilding; Michael Droller; Donald Trump
Journal:  Bladder Cancer       Date:  2018-10-03

Review 3.  Evolving immunotherapy strategies in urothelial cancer.

Authors:  Sam J Brancato; Keidren Lewi; Piyush K Agarwal
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

Review 4.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 5.  Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.

Authors:  Matthew S Farina; Kevin T Lundgren; Joaquim Bellmunt
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

Review 6.  Evolving immunotherapeutic strategies in bladder and renal cancer.

Authors:  T R L Griffiths; J K Mellon
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

7.  Intratumoral BCG and Corynebacterium parvum therapy of canine mammary tumours before radical mastectomy.

Authors:  A L Parodi; W Misdorp; J P Mialot; M Mialot; A A Hart; M Hurtrel; J C Salomon
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.

Authors:  Eleftherios P Diamandis; Robert C Bast; Phil Gold; T Ming Chu; John L Magnani
Journal:  Clin Chem       Date:  2012-11-30       Impact factor: 8.327

9.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 10.  The mechanism of action of BCG therapy for bladder cancer--a current perspective.

Authors:  Gil Redelman-Sidi; Michael S Glickman; Bernard H Bochner
Journal:  Nat Rev Urol       Date:  2014-02-04       Impact factor: 14.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.